Taking aspirin helps prevent blood clots from forming in your arteries. It also lowers your risk of a stroke or heart attack.
Aspirin may be used to prevent heart or artery disease. It can also help prevent strokes.
Aspirin helps get more blood flowing to your legs. It can treat a heart attack and prevent blood clots when you have an abnormal heartbeat. You probably will take aspirin after you have treatment for clogged arteries.
You will usually take aspirin as a pill. Talk to your doctor before taking aspirin every day. Your doctor may change your dose from time to time.
Aspirin can have side effects: diarrhea, a skin rash, itching, nausea, or stomach pain. Before you start taking aspirin, tell your doctor if you have bleeding problems. Tell your doctor if have stomach ulcers. Also tell your doctor if you are pregnant or breastfeeding.
Take your aspirin with food and water. This can reduce side effects. You may need to stop taking this medicine before surgery or dental work. Always talk to your doctor before you stop taking this medicine.
You may need medicine for other health problems. Ask your doctor if this is safe.
If you miss a dose of your aspirin, take it as soon as possible. If it is time for your next dose, take your usual amount. Do NOT take extra pills.
Store your medicines in a cool, dry place. Keep them away from children.
Call your doctor if you have side effects.
Side effects can be any signs of unusual bleeding:
Other side effects can be dizziness or difficulty swallowing.
Call your doctor if you have wheezing, breathing difficulty, or tightness or pain in your chest.
Side effects include swelling in your face or hands. Call your doctor if you have itching, hives, or tingling in your face or hands, very bad stomach pain, or a skin rash.
Blood thinners - aspirin; Antiplatelet therapy - aspirin
Becker RC, Meade TW, Berger PB, Ezekowitz M, O'Connor CM, Vorchheimer DA, et al. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):776S-814S.
Fraker TD Jr, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J et al. 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation. 2007;116:2762-2772.
Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009 Dec 1;120(22):2271-306.
Sobel M, Verhaeghe R; American College of Chest Physicians. Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:815S-843S.
Updated by: A.D.A.M. Editorial: David Zieve, MD, MHA, and David R. Eltz. Previously reviewed by Michael A. Chen, MD, PhD, Assistant Professor of Medicine, Division of Cardiology, Harborview Medical Center, University of Washington Medical School, Seattle, Washington (9/21/2012).
Notice: The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2012, A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.